(Q34346580)

1 August 2017

Formation and elimination of sulphamethoxazole hydroxylamine after oral administration of sulphamethoxazole (English)

1 reference

1 August 2017

van der Ven AJ

1

1 reference

1 August 2017

Mantel MA

2

1 reference

1 August 2017

Vree TB

3

1 reference

1 August 2017

Koopmans PP

4

1 reference

1 August 2017

van der Meer JW

5

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 August 1994

1 reference

British Journal of Clinical Pharmacology

1 August 2017

1 reference

1 August 2017

38

1 reference

1 August 2017

2

1 reference

1 August 2017

147-150

1 reference

Adverse Reactions to Trimethoprim-Sulfamethoxazole in Patients with the Acquired Immunodeficiency Syndrome

1 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364861

In vitro evaluation of a toxic metabolite of sulfadiazine.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364861

Synthesis and in vitro toxicity of hydroxylamine metabolites of sulfonamides.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364861

Systemic glutathione deficiency in symptom-free HIV-seropositive individuals

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364861

Adverse reactions to co-trimoxazole in HIV infection

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364861

MW/Pharm, an integrated software package for drug dosage regimen calculation and therapeutic drug monitoring

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364861

Refusal of zidovudine by HIV-positive patients

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364861

Sulfamethoxazole is metabolized to the hydroxylamine in humans

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364861

Pharmacokinetics of sulphamethoxazole in man: effects of urinary pH and urine flow on metabolism and renal excretion of sulphamethoxazole and its metabolite N4-acetylsulphamethoxazole

6 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1994.TB04339.X

Determination of the acetylator phenotype and pharmacokinetics of some sulphonamides in man

21 January 2018

1 reference

12 December 2020

Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity

1 reference

12 December 2020

Clinical pharmacokinetics of sulfonamides and their metabolites: an encyclopedia

1 reference

12 December 2020

Prominence of slow acetylator phenotype among patients with sulfonamide hypersensitivity reactions

1 reference

12 December 2020

Reactions of the nitroso and hydroxylamine metabolites of sulfamethoxazole with reduced glutathione. Implications for idiosyncratic toxicity

1 reference

12 December 2020

Diagnosis of sulfonamide hypersensitivity reactions by in-vitro "rechallenge" with hydroxylamine metabolites

1 reference

12 December 2020

10.1111/J.1365-2125.1994.TB04339.X

Identifiers

DOI

1 reference

1 August 2017

1 reference

1 August 2017

1 reference